MoneyWorks4Me

Sang Froid Labs India submits disclosure

19 May 2018 Evaluate

The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Milap Jadeja.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1226.95
Cipla 1329.40
Lupin 1922.60
Zydus Lifesciences 1126.10
View more..